248 filings
Page 2 of 13
SC 13G/A
ZLDPF
Zealand Pharma A/S
14 Feb 22
Zealand Pharma A/S / VAN HERK INVESTMENTS B.V. ownership change
12:27pm
6-K
ZLDPF
Zealand Pharma A/S
15 Dec 21
Zealand Pharma Announces Seven-Year, $200 Million Financing Agreement with Oberland Capital
4:08pm
6-K
ZLDPF
Zealand Pharma A/S
22 Nov 21
Company announcement – No. 70/ 2021
4:10pm
6-K
ZLDPF
Zealand Pharma A/S
19 Nov 21
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
4:05pm
6-K
ZLDPF
Zealand Pharma A/S
12 Nov 21
Company announcement – No. 67/ 2021
12:00am
6-K
ZLDPF
Zealand Pharma A/S
5 Nov 21
Current report (foreign)
4:05pm
S-8
ZLDPF
Zealand Pharma A/S
4 Oct 21
Registration of securities for employees
12:00am
6-K
ZLDPF
Zealand Pharma A/S
1 Oct 21
Current report (foreign)
6:12am
6-K
ZLDPF
Zealand Pharma A/S
7 Sep 21
New Employee Elected Director to the board of Zealand Pharma A/S
6:39am
6-K
ZLDPF
Zealand Pharma A/S
26 Aug 21
Current report (foreign)
2:43pm
6-K
ZLDPF
Zealand Pharma A/S
13 Aug 21
Current report (foreign)
4:19pm
6-K
ZLDPF
Zealand Pharma A/S
30 Jul 21
Current report (foreign)
1:15pm
6-K
ZLDPF
Zealand Pharma A/S
21 Jul 21
Current report (foreign)
1:57pm
6-K
ZLDPF
Zealand Pharma A/S
21 Jul 21
Current report (foreign)
1:55pm
6-K
ZLDPF
Zealand Pharma A/S
12 Jul 21
Current report (foreign)
1:04pm
6-K
ZLDPF
Zealand Pharma A/S
29 Jun 21
Current report (foreign)
4:48pm
6-K
ZLDPF
Zealand Pharma A/S
28 Jun 21
Current report (foreign)
5:19pm
6-K
ZLDPF
Zealand Pharma A/S
25 Jun 21
Zealand Pharma Announces U.S. Commercial Availability of ZEGALOGUE® (dasiglucagon) injection
9:17am
6-K
ZLDPF
Zealand Pharma A/S
4 Jun 21
Boehringer Ingelheim and Zealand Pharma Receive FDA Fast Track Designation for Investigational Treatment for NASH
6:37am
6-K
ZLDPF
Zealand Pharma A/S
27 May 21
Current report (foreign)
3:24pm